CARISOPRODOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Carisoprodol, and when can generic versions of Carisoprodol launch?
Carisoprodol is a drug marketed by Able, Accelrx Labs, Aurobindo Pharma, Chartwell Rx, Epic Pharma Llc, Hikma Intl Pharms, MLV, Natco, Nostrum Labs Inc, Novast Labs, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Wanbang Biopharms, Watson Labs, Watson Labs Teva, Wilshire Pharms Inc, and Ingenus Pharms Nj. and is included in thirty-two NDAs.
The generic ingredient in CARISOPRODOL is aspirin; carisoprodol; codeine phosphate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARISOPRODOL?
- What are the global sales for CARISOPRODOL?
- What is Average Wholesale Price for CARISOPRODOL?
Summary for CARISOPRODOL
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 32 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 4 |
Patent Applications: | 5,068 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARISOPRODOL |
What excipients (inactive ingredients) are in CARISOPRODOL? | CARISOPRODOL excipients list |
DailyMed Link: | CARISOPRODOL at DailyMed |
Recent Clinical Trials for CARISOPRODOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
Farmoquimica S.A. | Phase 3 |
Pharmagenix Projetos em Medicina FarmacĂȘutica Ltda. | Phase 3 |
Pharmacology for CARISOPRODOL
Drug Class | Muscle Relaxant |
Physiological Effect | Centrally-mediated Muscle Relaxation |